A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: A randomized prospective proof of concept study

Fertility and Sterility

Volumn 95, Issue 3, 2011, Pages 1174-1177

  Papanikolaou, Evangelos G ^a,b   Verpoest, Willem ^a   Fatemi, Human ^a   Tarlatzis, Basil ^b   Devroey, Paul ^a   Tournaye, Herman ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

agonist triggering; GnRH antagonist; OHSS; pregnancy; Recombinant LH

Indexed keywords

CETRORELIX; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; TRIPTORELIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; HUMAN; LOW DRUG DOSE; LUTEAL PHASE; NIDATION; OOCYTE MATURATION; OUTCOME ASSESSMENT; OVULATION; PILOT STUDY; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE;

ADULT; CHORIONIC GONADOTROPIN; DRUG THERAPY, COMBINATION; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; LUTEINIZING HORMONE; OVULATION; OVULATION INDUCTION; PILOT PROJECTS; PREGNANCY; PREGNANCY RATE; RECOMBINANT PROTEINS;

EID: 79951945981     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2010.09.023     Document Type: Article

References (24)

1. Gemzell C. Induction of ovulation with human gonadotropins. Recent Progr Horm Res 1965;21: 179-204.
2. Daughaday WH. The adenohypophysis. In: Williams RH, ed. Textbook of endocrinology. London: Saunders, 1981:80-6.
3. Weissman A, Lurie S, Zalel Y, Goldchmit R, Shoham Z. Human chorionic gonadotropin: pharmacokinetics of subcutaneous administration. Gynecol Endocrinol 1996;10:273-6. (Pubitemid 26343488)
4. Papanikolaou EG, Tournaye H, Verpoest W, Camus M, Vernaeve V, Van Steirteghem A, et al. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. Hum Reprod 2005;20:636-41. (Pubitemid 40425488)
5. Bourgain C, Ubaldi F, Tavaniotou A, Smitz J, Van Steirteghem AC, Devroey P. Endometrial hormone receptors and proliferation index in the periovulatory phase of stimulated embryo transfer cycles in comparison with natural cycles and relation to clinical pregnancy outcome. Fertil Steril 2002;78:237-44. (Pubitemid 34845894)
6. Smitz J, Devroey P, Faguer B, Bourgain C, Camus M, Van Steirteghem AC. A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement. Hum Reprod 1992;7:168-75.
7. Kol S. Luteolysis induced by gonadotropin-releasing hormone is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril 2004;8:1-5. (Pubitemid 38058315)
8. Griesinger G, Diedrich K, Devroey P, Kolibianakis EM. GnRH agonist for triggering final oocyte maturation in the GnRH-antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. Hum Reprod Update 2006;12:159-68. (Pubitemid 43239269)
9. Bodri D, Guillen JJ, Galindo A, Matro D, Pujol A, Coll O. Triggering with hCG or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertil Steril 2009;91: 365-71.
10. Humaidan P, Bungum L, Bungum M, Yding Andersen C. Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH-antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod Biomed Online 2006;13: 173-8. (Pubitemid 44207763)
11. Humaidan P, Ejdrup Bredkjær, Westergaard L, Yding Andersen C. 1500 IU hCG secures a normal clinical pregnancy outcome in IVF/ICSI GnRH-antagonist cycles in which ovulation was triggered with a GnRH agonist. Fertil Steril 2010;93:847-54.
12. The European Recombinant Human LH Study Group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab 1998;83:1507-14.
13. Humaidan P, Bungum M, Bungum L, Yding Andersen C. Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reprod Biomed Online 2004;8:635-43. (Pubitemid 38744939)
14. The European recombinant LH study group. Recombinant human luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J Clin Endocrinol Metab 2001;86:2607-18.
15. Fritz MA, McLachlan RI, Cohen NL, Dahl KD, Bremmer WJ, Soules MR. Onset and characteristics of the midcycle surge in bioactive and immunoactive luteinizing hormone secretion in normal women: influence of physiological variations in periovulatory ovarian steroid hormone secretion. J Clin Endocrinol Metab 1992;75:489-93.
16. Humaidan P, Papanikolaou EG, Tarlatzis B. GnRH-a to trigger final oocyte maturation: a time to reconsider. Hum Reprod 2009;24:2389-94.
17. Papanikolaou EG, Kolibianakis E, Devroey P. Emerging drugs in assisted reproduction. Expert Opin Emerg Drugs 2005;10:425-40. (Pubitemid 40695137)
18. Fauser BC, de Jong D, Olivennes F, Wramsby H, Tay C, Itskovitz-Eldor J, van Hooren HG. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH-antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab 2002;87: 709-15. (Pubitemid 34158241)
19. Griesinger G, Kolibianakis EM, Papanikolaou EG, Diedrich K, Van Steirteghem A, Devroey P, et al. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Fertil Steril 2007;88:616-21.
20. Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH-antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomised controlled study. Fertil Steril 2008;89:84-91.
21. Perrier d'Hauterive S, Berndt S, Tsampalas M, Charlet-Renard C, Dubois M, Bourgain C, et al. Dialogue between blastocyst hCG and endometrial LH/hCG receptor: which role in implantation? Gynecol Obstet Invest 2007;64:156-60.
22. Plante BJ, Kannan A, Bagchi MK, Yuan L, Young SL. Cyclic regulation of transcription factor C/EBP beta in human endometrium. Reprod Biol Endocrinol 2009;17:7-15.
23. Neulen J, Yan Z, Raczec S, Weindel K, Keck C, Weigh HA, et al. Human chorionic gonadotrop-independent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 1995;80:1967-71.
24. Humaidan P. Luteal phase rescue in high-risk OHSS patients by GnRH-a triggering in combination with low-dose hCG: a pilot study. Reprod Biomed Online 2009;18:630-4.